Research Study Summary
N.O.H. - A study for Parkinson's Disease patients with symptomatic low blood pressure.
The purpose of this research study is to determine whether Droxidopa can relieve the symptoms of neurogenic orthostatic hypotension (NOH) and whether it causes any side effects in people with symptomatic NOH.
Patient Inclusion Criteria:
- 18 years old
- clinical diagnosis of Parkinson's disease
- clinical diagnosis of symptomatic neurogenic orthostatic hypotension
- written informed consent
Patient Exclusion Criteria:
- Concomitant use of vasoconstricting agents for the purpose of increasing blood pressure
- Concomitant use of anti-hypertensive medication for the treatment of essential hypertension
- known or suspected alcohol or substance abuse within the past 12 months
- women who are pregnant or breast feeding
- closed angle glaucoma
- uncontrolled cardiac arrhythmia
- myocardial infarction within the past 2 years
- unstable angina
- congestive heart failure
- diabetic autonomic neuropathy
- history of cancer within the past 2 years
- ulcerative colitis or gastric bypass
- any major surgical procedure within 30 days of baseline
- previously treated with droxidopa
- currently receiving any investigational drug
- any condition or lab test result, which in the Investigator's judgement might result in an increased risk to the patient, or would affect their participation in the study. Additionally the Investigator has the ability to exclude a patient if for any reason they feel the subject is not a good candidate for the study or will not be able to follow study procedures.
To Learn more
Date Last Changed:
July 18, 2013
Clinical Trial Snapshot
- Both Male and Female
- 18 and up
- Overall Status
- Facility Type
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.